|

BMS-986453 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 2

Top Sponsors

  • Susan Bal1
  • Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1

Indications

  • Cancer2
  • Relapsed and/or Refractory Multiple Myeloma1
  • Multiple Myeloma1

Birmingham, Alabama2 trials

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

University of Alabama at Birmingham

Phase 1
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

University of Alabama at Birmingham

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.